七彩化學(300758.SZ):年產5000噸MXD6生產線計劃今年6月底前投入生產
格隆匯5月10日丨七彩化學(300758.SZ)在投資者互動平台表示,公司年產5,000噸MXD6生產線計劃今年6月底前投入生產;MXD6作為高性能工程塑料,其產品具有高強度、高剛性、耐高温、耐磨損和耐老化、耐化學性、阻燃性、高阻隔性能等特點,主要應用於汽車和無人機輕量化以及阻隔包裝材料。公司幾百噸級中試產品得到了很多客户的認可,並對大生產產品充滿期待。因此,低空經濟的發展對公司拓展該領域有很大助力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.